Lentykine 4 mg Capsule
17.00$
13.87$
Lentykine 4 mg capsules are specifically designed for the management of various cancer types, including recurrent or metastatic thyroid cancer, renal cell carcinoma in patients with prior chemotherapy, and advanced cases when paired with pembrolizumab. This innovative medication also addresses inoperable hepatocellular carcinoma and endometrial cancer that has either progressed post-chemotherapy or is unsuitable for surgical or radiation intervention. As a potent kinase inhibitor, Lentykine functions by obstructing the activity of abnormal proteins that drive cancer cell proliferation, effectively hindering the advancement of the disease. While Lentykine offers significant therapeutic benefits, it is essential to be aware of potential side effects, which may include fatigue, hypertension, and gastrointestinal disturbances. Patients should consult their healthcare provider to discuss these risks and monitor their response to treatment closely. This medication is a critical option for individuals facing challenging cancer diagnoses, providing hope through targeted therapy. Always follow your healthcare professional's instructions regarding dosage and administration to maximize the effectiveness of Lentykine.
الكمية
Active Pharmaceutical Ingredient
Uses
• Lentykine 4 mg capsule is indicated for the treatment of thyroid cancer that has recurred or metastasized, particularly in cases where radioactive iodine therapy is not a viable option. This medication helps to manage the progression of the disease and improve patient outcomes. By targeting specific pathways involved in cancer growth, Lentykine 4 mg capsule can be an essential part of the treatment regimen. It is typically used in patients who have limited treatment alternatives.
• In the context of advanced renal cell carcinoma (RCC), Lentykine 4 mg capsule is used in combination with everolimus. This dual therapy approach is intended for adults who have already undergone prior chemotherapy treatments. Lentykine 4 mg capsule plays a crucial role in inhibiting tumor growth and progression, thus offering a strategic option for managing this aggressive form of kidney cancer. This combination can enhance treatment efficacy and provide additional hope to patients facing advanced stages of RCC.
• Lentykine 4 mg capsule is also utilized for the management of hepatocellular carcinoma (HCC), which is the most common type of liver cancer. For patients who are not candidates for surgical intervention, Lentykine 4 mg capsule serves as an effective therapeutic option. It works by targeting the molecular mechanisms that drive tumor growth in the liver. This medication is particularly valuable for those seeking treatment alternatives when surgery is not possible.
• The use of Lentykine 4 mg capsule extends to specific cases of cancer where conventional treatments may fall short. Its targeted approach allows for a more focused attack on cancer cells, potentially leading to better management of the disease. Healthcare providers often consider Lentykine 4 mg capsule for patients who have exhausted other treatment options. This medication can thus play a significant role in the overall cancer treatment strategy, providing patients with additional choices in their care.
Benefits
Lentykine 4 mg Capsule works by targeting specific proteins that play a role in the growth and spread of cancer cells, thereby potentially slowing down or halting the progression of the tumour. Lentykine 4 is effective in treating certain types of cancer, such as thyroid cancer and kidney cancer, and in some cases, it can shrink tumours or reduce the symptoms associated with the disease. Lentykine 4 mg may cause fewer side effects compared to traditional chemotherapy and taken orally, which makes it easy to take and convenient for patients. Lentykine 4 mg Capsule can be used as a long-term treatment option for patients with advanced cancer, which can help to improve their quality of life and extend their lifespan.
Side Effects
Like all medication, Lentykine 4 mg Capsule may cause some side effects. If you experience any of these side effects, contact your doctor as soon as possible. Your doctor may be able to suggest ways to manage or reduce the severity of these side effects.
Most Common Side Effects
• Hoarse Voice
• Low or High Blood Pressure
• Hair Loss
• Swelling of Legs
• Tiredness
• Vomiting
• Nausea
• Indigestion
• Pain in Muscle and Joints
Common Side Effects
• Breathing Problems
• Blood Clot
• Dizziness
• Fever
• Bloody Stool
• Vision Problems
• Speaking Difficulty
How To Use
Lentykine 4 mg Capsule can be taken with or without food, but it is recommended to take it at the same time each day for optimal results. Dosage and frequency of use will be determined by your doctor based on your specific condition and may change over time. It is important that you follow your doctor's instructions and do not change the dosage or frequency of intake without their guidance.
Safety Advice
• Alcohol: It is not recommended to consume alcohol while taking Lentykine 4 mg Capsule. Alcohol may increase the risk of side effects or interfere with the effectiveness of the Lentykine 4 mg. It is best to talk to your doctor or pharmacist before consuming alcohol while taking any medicine.
• Kidney: Lentykine 4 mg Capsule should be used with caution in patients with Kidney disease. It is important that patients with kidney disease closely monitor kidney function while taking Lentykine 4 mg and report any unusual symptoms or changes in kidney function to their doctor. The dose of Lentykine 4 mg may need to be adjusted in patients with kidney disease.
• Breastfeeding: It is not recommended to breastfeed while taking Lentykine 4 mg. Lentykine 4 mg Capsule may pass into breast milk and harm the infant. If you are breastfeeding and taking Lentykine 4 mg, it is important to talk to your doctor about the possible risks and benefits of continuing to breastfeed. Your doctor will be able to help you make the best decision for you and your baby's health.
• Liver: Lentykine 4 mg Capsule should be used with caution in patients with liver disease. It is important that patients with liver disease closely monitor liver function while taking Lentykine 4 mg and report any unusual symptoms or changes in liver function to their doctor. The dose of Lentykine 4 mg may need to be adjusted in patients with liver disease.
• Pregnancy: Use of Lentykine 4 mg Capsule may be unsafe during pregnancy as animal studies indicate that it may harm the developing foetus. However, if you are pregnant or planning to become pregnant, it is important to talk to your doctor about the potential risks and benefits of taking Lentykine 4 mg during pregnancy. Your doctor will be able to help you make the best decision for you and your baby's health.
• Driving: Lentykine 4 mg Capsule may cause dizziness, fatigue, and difficulty concentrating and coordinating, which may affect your ability to drive a vehicle safely. It is important to follow your doctor's instructions and take necessary precautions such as avoiding driving a vehicle or operating heavy machinery if you suffer from the side effects of this Lentykine 4 mg.